The Safety and Efficacy of Median Nerve Electrical Stimulation for Improving Neurological Function Prognosis in Patients With Cardiac Arrest

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Median NerveComaPost Cardiac Arrest Brain Injury
Interventions
DEVICE

MNS

The MNS treatment group use the NeuroTrac™ Multi-TENS transcutaneous electrical stimulator to provide an asymmetric biphasic pulse train with a frequency of 35 Hz, an amplitude of 20 mA and a pulse width of 300 ms, which is on for 20 seconds and off for 50 seconds. The treatment lasts for 8 hours per day and the treatment course lasts for one week.

DEVICE

Sham stimulation

The sham stimulation treatment group utilized the same stimulation device and was subjected to a safe yet ineffective stimulation protocol for sham stimulation. The treatment lasts for 8 hours per day and the treatment course lasts for 14 days.

Trial Locations (1)

100020

Beijing Chao-Yang Hospital, Beijing

All Listed Sponsors
lead

Tang Ziren

OTHER

NCT06696690 - The Safety and Efficacy of Median Nerve Electrical Stimulation for Improving Neurological Function Prognosis in Patients With Cardiac Arrest | Biotech Hunter | Biotech Hunter